GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences:
|
TD Cowen 45th Annual Health Care Conference: |
|||||||||
|
Fireside Chat |
|||||||||
|
Date: |
Tuesday, March 4, 2025 |
||||||||
|
Time: |
9:10 – 9:40 a.m. Eastern Time (ET) |
||||||||
|
Location: |
Boston, MA |
||||||||
|
Conference |
|||||||||
|
Event: |
Investor Meetings |
||||||||
|
Date: |
Tuesday, March 4, 2025 |
||||||||
|
Leerink Partners 2025 Global Healthcare Conference: |
|||||||||
|
Presentation |
|||||||||
|
Date: |
Tuesday, March 11, 2025 |
||||||||
|
Time: |
3:40 – 4:10 p.m. ET |
||||||||
|
Location: |
Miami Beach, FL |
||||||||
|
Conference |
|||||||||
|
Event: |
Investor Meetings |
||||||||
|
Date: |
Tuesday, March 11, 2025 |
||||||||
|
Jefferies Biotech on the Beach Summit: |
|||||||||
|
Conference |
|||||||||
|
Event: |
Investor Meetings |
||||||||
|
Date: |
Wednesday, March 12, 2025 |
||||||||
|
Location:
|
Miami Beach, FL |
||||||||
A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company’s website at ir.novavax.com, with replays available for 30 days after the conferences.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world’s most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company’s growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company’s core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
SOURCE Novavax, Inc.
Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…
Top-line data anticipated in early Q3 2025. BOSTON--(BUSINESS WIRE)--Sensory Cloud Inc., a health technology company…
The Summit will bring together supply chain, commercial, finance, IT, and procurement leaders to explore…
Medical Advisory Board additions support company’s growing product offerings across women’s health and family building…
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”),…
– Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="176px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
